| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population | Chiang Y.-H.; Chang Y.-C.; Lin H.-C.; Huang L.; Cheng C.-C.; Wang W.-T.; Cheng H.-I.; Su N.-W.; Chen C.G.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; WEN-CHIEN CHOU ; Lim K.-H.; Kuo Y.-Y. | Oncotarget | |||
| 2012 | Growth behavior of aragonite under the influence of magnetic field, temperature, and impurity | Wang S.S.S. ; Chang M.-C.; Chang H.-C.; Chang M.-H.; Tai C.Y. | Industrial and Engineering Chemistry Research | |||
| 2014 | Growth of calcite seeds in a magnetized environment | Tai C.Y.; Chang M.-C.; Liu C.-C.; Wang S.S.-S. | Journal of Crystal Growth | |||
| 2014 | Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement | Ko B.-S.; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; HWEI-FANG TIEN | International Journal of Hematology | |||
| 2014 | Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement | BOR-SHENG KO ; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; Tang J.-L.; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; Tien H.-F. | International Journal of Hematology | |||
| 2014 | Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement | Ko B.-S.; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; JIH-LUH TANG ; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; Tien H.-F. | International Journal of Hematology | |||
| 1999 | Helicobacter pylori stool antigen (HpSA) test - A simple, accurate and non-invasive test for detection of Helicobacter pylori infection | Chang M.-C.; MING-SHIANG WU ; Wang H.-H.; Wang H.-P.; Lin J.-T. | Hepato-Gastroenterology | |||
| 1999 | Helicobacter pylori stool antigen (HpSA) test - A simple, accurate and non-invasive test for detection of Helicobacter pylori infection | Chang M.-C.; Wu M.-S.; Wang H.-H.; HSIU-PO WANG ; Lin J.-T. | Hepato-Gastroenterology | |||
| 2014 | Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma | Chang M.-C.; Chen C.-H.; Liang J.-D.; YU-WEN TIEN ; Hsu C.; Wong J.-M.; Chang Y.-T. | World Journal of Gastroenterology | |||
| 2014 | Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma | Chang M.-C.; Chen C.-H.; Liang J.-D.; Tien Y.-W.; Chiun Hsu ; Wong J.-M.; Chang Y.-T. | World Journal of Gastroenterology | |||
| 2016 | A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer a high portal venous CTC count predicts liver metastases | YU-WEN TIEN ; Kuo H.-C.; Ho B.-I.; Chang M.-C.; Chang Y.-T.; Cheng M.-F.; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Huang C.-Y.; Shew J.-Y.; Chang Y.C.; Lee E.Y.H.P.; Lee W.-H. | Medicine (United States) | |||
| 2016 | A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer a high portal venous CTC count predicts liver metastases | Tien Y.W.; Kuo H.-C.; Ho B.-I.; Chang M.-C.; Chang Y.-T.; MEI-FANG CHENG ; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Huang C.-Y.; Shew J.-Y.; Chang Y.C.; Lee E.Y.H.P.; Lee W.-H. | Medicine (United States) | |||
| 2019 | High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells | Hu C.-M.; Tien S.-C.; Hsieh P.-K.; YUNG-MING JENG ; Chang M.-C.; Chang Y.-T.; Chen Y.-J.; Chen Y.-J.; Lee E.Y.-H.P.; Lee W.-H. | Cell Metabolism | |||
| 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; Chiang Y.-C.; Chen Y.-L.; Hsieh C.-Y.; Chen C.-A. | British Journal of Cancer | |||
| 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | Cheng W.-F.; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; Chiang Y.-C.; Chen Y.-L.; Hsieh C.-Y.; CHI-AN CHEN | British Journal of Cancer | |||
| 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | Cheng W.-F.; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; Chiang Y.-C.; YU-LI CHEN ; Hsieh C.-Y.; Chen C.-A. | British Journal of Cancer | |||
| 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | Cheng W.-F.; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; Chiang Y.-C.; Chen Y.-L.; CHANG-YAO HSIEH ; Chen C.-A. | British Journal of Cancer | |||
| 2015 | High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection | Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; MING-JIUM SHIEH ; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. | Clinical Gastroenterology and Hepatology | |||
| 2015 | High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection | Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; CHIA-TUNG SHUN ; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. | Clinical Gastroenterology and Hepatology | |||
| 2015 | High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection | Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; CHIEN-CHIH TUNG ; Leong Y.-L.; Wang T.-H.; Wong J.-M. | Clinical Gastroenterology and Hepatology |
